ArticleJAMA network open2022
Development and Validation of Machine Models Using Natural Language Processing to Classify Substances Involved in Overdose Deaths.
Article in JAMA network open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- A fairness framework for natural language processing in substance use disorders and overdose.PLOS digital health · 2026Article
- Improving drug identification in overdose death surveillance by using clinical natural language processing models.Journal of forensic sciences · 2026Article
- Enhancing substance use detection in clinical notes with large language models.Drug and alcohol dependence · 2025Article
- Identifying emergency department patients at high risk for opioid overdose using natural language processing and machine learning.Journal of substance use and addiction treatment · 2025Article
- Leveraging pooled medical examiner records to surveil complex and emerging patterns of polysubstance use in the United States.The International journal on drug policy · 2025Article
- Clinical applications of large language models in medicine and surgery: A scoping review.The Journal of international medical research · 2025Article
- Speak and You Shall Predict: Evidence That Speech at Initial Cocaine Abstinence Is a Biomarker of Long-Term Drug Use Behavior.Biological psychiatry · 2025Article
- Artificial intelligence approaches for anti-addiction drug discovery.Digital discovery · 2025Review
- Enhancing Substance Use Detection in Clinical Notes with Large Language Models.Research square · 2025Article
- Explainability Enhanced Machine Learning Model for Classifying Intellectual Disability and Attention-Deficit/Hyperactivity Disorder With Psychological Test Reports.Journal of Korean medical science · 2025Article
- Identifying Self-Disclosures of Use, Misuse and Addiction in Community-based Social Media Posts.Findings of ACL. NAACL · 2024Article
- ODD: A Benchmark Dataset for the Natural Language Processing Based Opioid Related Aberrant Behavior Detection.Proceedings of the conference. Association for Computational Linguistics. North American Chapter. Meeting · 2024Article
- Question-answering system extracts information on injection drug use from clinical notes.Communications medicine · 2024Article
- Natural Language Processing and Machine Learning to Identify People Who Inject Drugs in Electronic Health Records.Open forum infectious diseases · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Importance: Overdose is one of the leading causes of death in the US; however, surveillance data lag considerably from medical examiner determination of the death to reporting in national surveillance reports. Objective: To automate the classification of deaths related to substances in medical examiner data using natural language processing (NLP) and machine learning (ML). Design, Setting, and Participants: Diagnostic study comparing different natural language processing and machine learning algorithms to identify substances related to overdose in 10 health jurisdictions in the US from January 1, 2020, to December 31, 2020. Unstructured text from 35 433 medical examiner and coroners' death records was examined. Exposures: Text from each case was manually classified to a substance that was related to the death. Three feature representation methods were used and compared: text frequency-inverse document frequency (TF-IDF), global vectors for word representations (GloVe), and concept unique identifier (CUI) embeddings. Several ML algorithms were trained and best models were selected based on F-scores. The best models were tested on a hold-out test set and results were reported with 95% CIs. Main Outcomes and Measures: Text data from death certificates were classified as any opioid, fentanyl, alcohol, cocaine, methamphetamine, heroin, prescription opioid, and an aggregate of other substances. Diagnostic metrics and 95% CIs were calculated for each combination of feature extraction method and machine learning classifier. Results: Of 35 433 death records analyzed (decedent median age, 58 years [IQR, 41-72 years]; 24 449 [69%] were male), the most common substances related to deaths included any opioid (5739 [16%]), fentanyl (4758 [13%]), alcohol (2866 [8%]), cocaine (2247 [6%]), methamphetamine (1876 [5%]), heroin (1613 [5%]), prescription opioids (1197 [3%]), and any benzodiazepine (1076 [3%]). The CUI embeddings had similar or better diagnostic metrics compared with word embeddings and TF-IDF for all substances except alcohol. ML classifiers had perfect or near perfect performance in classifying deaths related to any opioids, heroin, fentanyl, prescription opioids, methamphetamine, cocaine, and alcohol. Classification of benzodiazepines was suboptimal using all 3 feature extraction methods. Conclusions and Relevance: In this diagnostic study, NLP/ML algorithms demonstrated excellent diagnostic performance at classifying substances related to overdoses. These algorithms should be integrated into workflows to decrease the lag time in reporting overdose surveillance data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.